Citizens JMP downgraded Vor Bio (VOR) to Market Perform from Outperform without a price target Vor is exploring strategic alternatives and ended all development programs based on currently available clinical data from its key clinical programs and a challenging fundraising environment, the analyst tells investors in a research note. The firm views the shares as trading at fair value.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VOR:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue